Profil
Robert McRae is President & Chief Operating Officer at Sidewinder Therapeutics, Inc. since 2025.
Former roles include Chief Operating Officer at Palisade Bio, Inc. from 2023 to 2023, Vice President-Operations at Viracta Subsidiary, Inc. from 2018 to 2020, and Vice President-Operations & Strategic Alliances at Viracta Therapeutics, Inc. Education includes undergraduate studies at Wright State University (Ohio).
Postes actifs de Robert McRae
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Robert McRae
| Sociétés | Poste | Fin |
|---|---|---|
| PALISADE BIO, INC. | Directeur des opérations | 01/05/2023 |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Directeur des opérations | - |
Formation de Robert McRae
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Wright State University (Ohio)
Wright State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
















